-
Je něco špatně v tomto záznamu ?
Monitoring of CD38high expression in peripheral blood CD8+ lymphocytes in patients after kidney transplantation as a marker of cytomegalovirus infection
Olga Ticha, Martina Stouracova, Milan Kuman, Pavel Studenik, Tomas Freiberger, Jiri Litzman
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS9894
MZ0
CEP - Centrální evidence projektů
- MeSH
- antigeny CD38 biosyntéza MeSH
- biologické markery metabolismus MeSH
- CD8-pozitivní T-lymfocyty imunologie metabolismus patologie MeSH
- cytomegalovirové infekce komplikace diagnóza imunologie MeSH
- Cytomegalovirus patogenita fyziologie MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- monitorování fyziologických funkcí metody MeSH
- prediktivní hodnota testů MeSH
- rejekce štěpu komplikace diagnóza imunologie MeSH
- retrospektivní studie MeSH
- senzitivita a specificita MeSH
- transplantace ledvin MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Cytomegalovirus (CMV) infection is a life-threatening complication after solid organ transplantation. It usually appears in the first months after transplantation as a consequence of immunosuppression. The goal of this study was to evaluate the clinical significance of CD38(high)/CD3(+)8(+) percentages in the detection of CMV infection in patients after kidney transplantation. METHODS: In this retrospective study, 269 patients were monitored 2-3 months after renal transplantation for the percentage of CD38(high)/CD3(+)8(+) lymphocytes estimated by flow cytometry and for the number of CMV DNA copies in peripheral blood using a real-time polymerase chain reaction. RESULTS: CMV infection was diagnosed in 12 (4.5%) patients between the 31st and 63rd days after transplantation, and all of them had percentages of CD38(high)/CD3(+)8(+) T lymphocytes above 20%. In 4 of them, CMV DNAemia in peripheral blood was not detected, and 2 of these suffered from tissue-invasive CMV disease. In 7 patients with CMV DNAemia, the CD38(high)/CD3(+)8(+) T lymphocyte percentage did not exceed 20%, and these patients did not develop CMV infection requiring antiviral treatment. In 23 additional patients, a CD38(high)/CD3(+)CD8(+) percentage above 20% was recorded without CMV DNAemia. All of the remaining 234 patients never exceeded the arbitrary limit of 20%. The estimated sensitivity and specificity were 100% and 91% using clinical decision on the presence of CMV infection as a reference value, respectively. The estimated negative predictive value was 100%; however, the estimated positive predictive value was quite low (34%). CONCLUSIONS: The CD38(high)/CD3(+)8(+) lymphocyte percentage seems to be a useful additional diagnostic marker for CMV infection in patients after kidney transplantation, especially when patients are in the risk of a tissue-invasive disease when CMV DNA copies may not be detectable in peripheral blood.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027319
- 003
- CZ-PrNML
- 005
- 20160301181124.0
- 007
- ta
- 008
- 120816s2010 enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.trim.2010.10.002 $2 doi
- 035 __
- $a (PubMed)20951204
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Tichá, Olga $u Department of Clinical Immunology and Allergology, St. Anne's Faculty Hospital, Masaryk University, Brno, Czech Republic. olga.ticha@fnusa.cz $7 xx0199420
- 245 10
- $a Monitoring of CD38high expression in peripheral blood CD8+ lymphocytes in patients after kidney transplantation as a marker of cytomegalovirus infection / $c Olga Ticha, Martina Stouracova, Milan Kuman, Pavel Studenik, Tomas Freiberger, Jiri Litzman
- 520 9_
- $a BACKGROUND: Cytomegalovirus (CMV) infection is a life-threatening complication after solid organ transplantation. It usually appears in the first months after transplantation as a consequence of immunosuppression. The goal of this study was to evaluate the clinical significance of CD38(high)/CD3(+)8(+) percentages in the detection of CMV infection in patients after kidney transplantation. METHODS: In this retrospective study, 269 patients were monitored 2-3 months after renal transplantation for the percentage of CD38(high)/CD3(+)8(+) lymphocytes estimated by flow cytometry and for the number of CMV DNA copies in peripheral blood using a real-time polymerase chain reaction. RESULTS: CMV infection was diagnosed in 12 (4.5%) patients between the 31st and 63rd days after transplantation, and all of them had percentages of CD38(high)/CD3(+)8(+) T lymphocytes above 20%. In 4 of them, CMV DNAemia in peripheral blood was not detected, and 2 of these suffered from tissue-invasive CMV disease. In 7 patients with CMV DNAemia, the CD38(high)/CD3(+)8(+) T lymphocyte percentage did not exceed 20%, and these patients did not develop CMV infection requiring antiviral treatment. In 23 additional patients, a CD38(high)/CD3(+)CD8(+) percentage above 20% was recorded without CMV DNAemia. All of the remaining 234 patients never exceeded the arbitrary limit of 20%. The estimated sensitivity and specificity were 100% and 91% using clinical decision on the presence of CMV infection as a reference value, respectively. The estimated negative predictive value was 100%; however, the estimated positive predictive value was quite low (34%). CONCLUSIONS: The CD38(high)/CD3(+)8(+) lymphocyte percentage seems to be a useful additional diagnostic marker for CMV infection in patients after kidney transplantation, especially when patients are in the risk of a tissue-invasive disease when CMV DNA copies may not be detectable in peripheral blood.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a antigeny CD38 $x biosyntéza $7 D051997
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a CD8-pozitivní T-lymfocyty $x imunologie $x metabolismus $x patologie $7 D018414
- 650 _2
- $a Cytomegalovirus $x patogenita $x fyziologie $7 D003587
- 650 _2
- $a cytomegalovirové infekce $x komplikace $x diagnóza $x imunologie $7 D003586
- 650 _2
- $a rejekce štěpu $x komplikace $x diagnóza $x imunologie $7 D006084
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a transplantace ledvin $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a monitorování fyziologických funkcí $x metody $7 D008991
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Štouračová, Martina $u Department of Clinical Immunology and Allergology, St. Anne's Faculty Hospital, Masaryk University, Brno, Czech Republic $7 xx0079456
- 700 1_
- $a Kuman, Milan, $u Centre for Cardiovascular Surgery and Transplantation Brno, Brno, Czech Republic $d 1953- $7 xx0176002
- 700 1_
- $a Studeník, Pavel, $u Centre for Cardiovascular Surgery and Transplantation Brno, Brno, Czech Republic $d 1952-2019 $7 nlk20050170294
- 700 1_
- $a Freiberger, Tomáš $u Centre for Cardiovascular Surgery and Transplantation Brno, Brno, Czech Republic $7 xx0071641
- 700 1_
- $a Litzman, Jiří, $u Department of Clinical Immunology and Allergology, St. Anne's Faculty Hospital, Masaryk University, Brno, Czech Republic $7 xx0000488 $d 1958-
- 773 0_
- $w MED00006022 $t Transplant immunology $x 1878-5492 $g Roč. 24, č. 1 (2010), s. 50-56
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20951204 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20160301180840 $b ABA008
- 999 __
- $a ok $b bmc $g 949361 $s 784665
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 24 $c 1 $d 50-56 $e 20101014 $i 1878-5492 $m Transplant immunology $n Transpl Immunol $x MED00006022
- GRA __
- $a NS9894 $p MZ0
- LZP __
- $b NLK112 $a Pubmed-20120816/11/02